Results 41 to 50 of about 542,903 (199)

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial

open access: yes, 2023
Objective To compare the efficacy and safety of hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy in the treatment of malignant pleural or peritoneal effusion.Methods A randomized ...
Jie Min   +14 more
core   +1 more source

Effect of Intraperitoneal Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy

open access: yesTechnology in Cancer Research & Treatment, 2023
Despite extensive treatment with surgery and chemotherapy many patients with peritoneal metastases from colorectal cancer experience intraperitoneal disease relapse. The α-emitting 224 radium-labelled microparticle radionuclide therapeutic Radspherin® is
Ebbe Billmann Thorgersen MD, PhD   +6 more
doaj   +1 more source

Pharmacological principles of intraperitoneal and bidirectional chemotherapy

open access: yes, 2017
Intraperitoneal chemotherapy is associated with a significant pharmacokinetic and pharmacodynamic benefit and can, alone or in combination with systemic chemotherapy (bidirectional chemotherapy), be used for treating primary and secondary peritoneal ...
Odysseas Zoras   +4 more
core   +1 more source

Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC

open access: yesPleura and Peritoneum, 2022
Two surgical techniques used for peritoneal metastasis involve a risk of exposure to antineoplastic drugs (ADs): hyperthermic intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Benoist Hubert   +8 more
doaj   +1 more source

Systematic review of intraperitoneal chemotherapy for gastric cancer.

open access: yes, 2011
BACKGROUND Gastric cancer with peritoneal carcinomatosis has a poor prognosis. Intraperitoneal chemotherapy has been proposed as a treatment option. This systematic review examined recent literature to determine the role of intraperitoneal chemotherapy ...
Matharu, Gulraj   +5 more
core   +1 more source

Intraperitoneal chemotherapy for peritoneal metastases of gastric origin:A systematic review and meta-analysis

open access: yes, 2023
Background:Gastric cancer with peritoneal metastases is associated with a dismal prognosis. Catheter-based intraperitoneal (IP) chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC) are methods to deliver chemotherapy ...
Nasserinejad, K   +8 more
core   +1 more source

Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer [PDF]

open access: yes, 2016
\(\bf Background:\) Intraperitoneal chemotherapy is used to treat peritoneal cancer. The pattern of gene expression changes of peritoneal cancer during intraperitoneal chemotherapy has not been studied before.
Reymond, Marc A.   +7 more
core   +3 more sources

Primary ovarian high-grade endometrial stromal sarcoma: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Primary ovarian high-grade endometrial stromal sarcoma is a very rare disease. Even though it has poor prognosis, the gold standard treatment has not been established owing to its rarity.
Ji Sun Lee   +5 more
doaj   +1 more source

Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points.

open access: yes, 2014
Comment in Response to: "hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer should be proposed in eight time points". [Eur J Surg Oncol. 2014] Comment on Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic
DE IACO, PIERANDREA   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy